Leading Regenerative Stem Cell Therapy in New York City • Call +1 (917) 123-4567
Leveraging advanced Mesenchymal Stem Cell (MSC) treatments to regenerate tissue, relieve chronic pain, and combat neurodegenerative conditions—using your body’s natural healing power.
Combined Clinical Experience
Cellular Deployments Tracked
Every protocol is built around your diagnosis, imaging, and functional goals — never a one-size-fits-all package.
Regenerative SVF therapy targeting cartilage loss, stiffness, and joint inflammation.
Precision deployment for degenerative discs and chronic lower-back pain.
Shoulders, hips, and ankles restored through targeted cellular repair.
Support for nerve conduction, sensation, and pain modulation.
Remyelination research protocols with immune-modulating MSC deployment.
Functional recovery programs focused on mobility, fatigue, and quality of life.
Faster injury recovery for tendons, ligaments, and soft tissue.
Systemic cellular renewal protocols for vitality and healthy aging.
MSCs are isolated from your own adipose (fat) tissue or bone marrow — no donor material.
Cells migrate to inflamed, damaged tissue and signal local repair pathways.
Restorative exosomes and growth factors are secreted directly at the injury site.
The immune response is rebalanced, supporting native tissue regeneration.
Using your own cells minimizes immune rejection risk and adverse reactions.
Delivered via targeted intra-articular injection, IV, or specialized intrathecal methods depending on your condition.
Reduces pro-inflammatory cytokines (TNF-alpha, IL-6) while raising healing cytokines such as IL-10.
Comprehensive review of your medical history, MRI scans, and mobility goals.
Minimally invasive procedure under gentle local anesthesia — approximately 20 minutes.
Isolation of high-viability stem cells using automated, closed-system technology.
Direct injection into affected joints or spine, or an intravenous route for systemic restoration.
Cellular therapy works best inside a body prepared to heal. Our integrative philosophy pairs every deployment with metabolic optimization — personalized diet strategies, caloric restriction, intermittent fasting, sleep and movement protocols — to maximize stem cell viability and long-term treatment success.
Outcomes are tracked continuously — up to five years post-deployment — so every protocol is measured.
Cases tracked with sustained pain reduction and improved mobility over 5-year follow-ups.
Patient outcome reports demonstrating structural relief and functional improvement.
Documented cases demonstrating high safety profiles across nationwide network tracking.
“I could barely make it down the block. Eight months after my knee deployment I’m walking three miles a day without a brace.”
Severe knee osteoarthritis · Brooklyn, NY
“Two surgeons told me fusion was my only option. The MedGenixx protocol gave me my mornings back — no surgery, no opioids.”
Chronic lumbar disc pain · Manhattan, NY
“My fatigue dropped and my hand coordination improved measurably. For the first time in years I feel like I’m gaining ground.”
Multiple sclerosis · Queens, NY
“Autologous MSC deployment is one of the most promising tools we have for inflammatory joint disease. Patient selection and precise delivery are everything.”
Regenerative Medicine Physician
“Closed-system processing and consistent outcome tracking are what separate a serious clinical program from the rest.”
Clinical Director, Cellular Therapeutics
“Six weeks after treatment I was back to competitive training. The recovery curve was unlike anything I’d experienced.”
Rotator cuff & tendon repair · NYC
Our protocols are autologous — the cells come from your own body — and are processed in an automated, closed system that never exposes them to the environment. This approach has an extensive safety history, with more than 17,000 documented cases tracked across network reporting and no reliance on donor material or immunosuppressive drugs.
From you. Mesenchymal stem cells are harvested from your own adipose (fat) tissue or bone marrow during a short, minimally invasive procedure performed under local anesthesia.
HSCT requires harsh conditioning chemotherapy to ablate the immune system. MSC therapy is fundamentally different: it focuses on tissue regeneration, immune modulation, and anti-inflammation without conditioning drugs, hospitalization, or immune ablation.
Most patients notice early changes in pain and mobility within 4 to 12 weeks as tissue repair progresses, with continued improvement over 6 to 12 months. We track outcomes for up to five years so your progress is measured, not assumed.
Share a few details and our clinical team will contact you to schedule.
Mesenchymal stem cell therapies are evaluated individually. Submitting this form is not a medical diagnosis.
Prefer to talk it through? Call us directly — consultations are available Monday through Friday.
+1 (917) 123-4567
info@example.com
450 Lexington Avenue, Suite #4114, NY, NY 10017